Livzon Pharmaceutical Group continues A-share buyback efforts

Livzon Pharmaceutical Group has announced its latest repurchases of A-shares, which are traded on the Shenzhen Stock Exchange. On August 27, 2025, the company bought back 72,600 A-shares at prices ranging from 40.62 yuan to 41.72 yuan per share, totaling 2,997,593 yuan. These repurchases contribute to a cumulative total of 72,600 shares that are intended for cancellation.

The repurchased A-shares represent ongoing buyback activities, with the company noting purchases spanning from late 2024 through August 2025. These include significant repurchases such as 561,400 A-shares on January 14, 2025, at 35.62 yuan, and 558,400 A-shares on February 13, 2025, at 35.81 yuan. The company's total issued H-shares (not including treasury shares) as of August 27, 2025, remains unchanged at 299,807,117.

The disclosure confirms that all share repurchases adhere to the requirements of the Main Board Listing Rules and relevant local regulations. The company has no treasury shares, and the buyback initiatives are part of its approved capital management strategy.